ALPS Company Profile and Key Details

ALPS has shown mixed momentum, gaining 3.95% over the past week and -91.75% over the past quarter, though year-to-date performance is up 16.17%. Short-term trend indicators are bullishly aligned (SMA20 5.9%, SMA50 3.92%, SMA200 -86.15%). The stock’s 14-day RSI is 51.68 (neutral), while the ATR of 0.09 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -93.4% below its high and over 76.08% above its low. Average 10-day trading volume of 73.55 thousand shares is below the 3-month average of 113.36 thousand, indicating normal recent market interest.

Alps Group Inc last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.46. This means the shares are trading below this model’s fair value.

The stock is currently mid-range between its 52-week high and low $0.23 and $2.90. With a market capitalization of about $52.38 million, Alps Group Inc is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.06). Key stats such as the average daily volume over the past year has been around 117.78 thousand shares, volume is running light vs its 52-week average. Headquartered in Kuala Lumpur, WP, Alps Group Inc operates in the Healthcare sector and the Biotechnology industry. Led by CEO Seng Kong Tham, the company employs approximately 2 people and listed since October 31, 2025. Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions.

Alps Group Inc trades at a P/E ratio of -0.02, slightly below the S&P 500 average, with a price-to-sales ratio of 15.33 and a price-to-book ratio of -0.37 indicating negative book value, which may reflect financial stress. The P/FCF stands at -75.9, also below market averages.

Alps Group Inc (NASDAQ:ALPS) shares are up 16.17% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Alps Group Inc trading at a premium to the broader market with a P/E of -0.02. Our AI forecast model points to short-term weakness (-26.94% over two weeks), a medium-term fall (-80.94% over three months), and a longer-term loss (-55.53% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Alps Group Inc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -26.94%, with price expected at $0.23 by September 08, 2026, within a range of $0.20 to $0.26 3-Month Outlook: Projected fall of -80.94%, reaching $0.06 by November 23, 2026, with a range of $0.04 to $0.08. 1-Year Outlook: Projected loss of -55.53%, with price at $0.14 by August 25, 2027, within a range of $0.11 to $0.15.